Solventum Corporation (SOLV) EV/EBIT Ratio: 8.73x
Is Solventum Corporation’s EV/EBIT ratio high or low?
Solventum Corporation's EV/EBIT ratio of 8.73x is 50% below its 2-year average of 17.38x, near the low end of its 2-year range (6.93x–29.11x).
As of Friday, June 12, 2026. 58.20% below its 12-month average of 20.88x.
SOLV EV/EBIT Ratio Chart
SOLV Average EV/EBIT Ratio Chart
SOLV Current vs Average EV/EBIT Ratio Chart
SOLV EV/EBIT Ratio Metrics
EV/EBIT RATIO
8.73x
EV/EBIT RATIO AVG TTM
20.88x
EV/EBIT RATIO AVG 3Y
17.38x
EV/EBIT RATIO AVG 5Y
17.38x
EV/EBIT RATIO AVG 10Y
17.38x
EV/EBIT RATIO AVG 15Y
17.38x
EV/EBIT RATIO AVG 20Y
17.38x
CURRENT VS TTM AVG
-58.20%
CURRENT VS 3Y AVG
-49.76%
CURRENT VS 5Y AVG
-49.76%
CURRENT VS 10Y AVG
-49.76%
CURRENT VS 15Y AVG
-49.76%
CURRENT VS 20Y AVG
-49.76%
SOLV Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 8.73x | 20.88x | 17.38x | 17.38x |
| Align Technology, Inc. (ALGN) | $12.64B | 19.72x | 19.30x | 26.45x | 31.46x |
| Baxter International Inc. (BAX) | $10.58B | N/A | 442.63x | 243.35x | 134.31x |
| Hologic, Inc. (HOLX) | $16.97B | 24.28x | 22.66x | 24.05x | 18.32x |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 25.46x | 62.77x | 38.53x | 35.14x |
| Tempus AI, Inc. (TEM) | $8.65B | N/A | -26.05x | -27.91x | -28.92x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 36.55x | 38.06x | 32.83x | 33.28x |
| Moderna, Inc. (MRNA) | $19.70B | N/A | 23.08x | 30.94x | 30.94x |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 232.28x | 99.26x | 147.55x | 147.55x |
| BioNTech SE (BNTX) | $22.39B | N/A | 4.91x | 5.85x | 5.85x |
Solventum Corporation EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Solventum Corporation (SOLV)?
- The EV/EBIT ratio for SOLV stock is 8.73x.
- Is Solventum Corporation's EV/EBIT ratio high or low?
- Solventum Corporation's EV/EBIT ratio of 8.73x is 50% below its 2-year average of 17.38x, near the low end of its 2-year range (6.93x–29.11x).
- What is the TTM average EV/EBIT ratio for Solventum Corporation (SOLV)?
- The TTM average EV/EBIT ratio for SOLV stock is 20.88x.
- What is the 3Y average EV/EBIT ratio for Solventum Corporation (SOLV)?
- The 3Y average EV/EBIT ratio for SOLV stock is 17.38x.
- What is the 5Y average EV/EBIT ratio for Solventum Corporation (SOLV)?
- The 5Y average EV/EBIT ratio for SOLV stock is 17.38x.
- What is the 10Y average EV/EBIT ratio for Solventum Corporation (SOLV)?
- The 10Y average EV/EBIT ratio for SOLV stock is 17.38x.
- What is the 15Y average EV/EBIT ratio for Solventum Corporation (SOLV)?
- The 15Y average EV/EBIT ratio for SOLV stock is 17.38x.
- What is the 20Y average EV/EBIT ratio for Solventum Corporation (SOLV)?
- The 20Y average EV/EBIT ratio for SOLV stock is 17.38x.
Solventum Corporation EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-11 | 8.73x |
| 2026-06-10 | 8.87x |
| 2026-06-09 | 9.00x |
| 2026-06-08 | 8.69x |
| 2026-06-05 | 8.88x |
| 2026-06-04 | 9.00x |
| 2026-06-03 | 8.66x |
| 2026-06-02 | 8.50x |
| 2026-06-01 | 8.45x |
| 2026-05-29 | 8.38x |
| 2026-05-28 | 8.46x |
| 2026-05-27 | 8.45x |
| 2026-05-26 | 8.49x |
| 2026-05-22 | 8.53x |
| 2026-05-21 | 8.53x |
| 2026-05-20 | 8.47x |
| 2026-05-19 | 8.36x |
| 2026-05-18 | 8.47x |
| 2026-05-15 | 8.32x |
| 2026-05-14 | 8.33x |
| 2026-05-13 | 8.33x |
| 2026-05-12 | 8.39x |
| 2026-05-11 | 8.31x |
| 2026-05-08 | 8.25x |
| 2026-05-07 | 8.10x |
| 2026-05-06 | 8.05x |
| 2026-05-05 | 7.88x |
| 2026-05-04 | 7.33x |
| 2026-05-01 | 7.26x |
| 2026-04-30 | 7.32x |
| 2026-04-29 | 7.25x |
| 2026-04-28 | 7.33x |
| 2026-04-27 | 7.51x |
| 2026-04-24 | 7.41x |
| 2026-04-23 | 7.45x |
| 2026-04-22 | 7.46x |
| 2026-04-21 | 7.45x |
| 2026-04-20 | 7.54x |
| 2026-04-17 | 7.57x |
| 2026-04-16 | 7.44x |
| 2026-04-15 | 7.46x |
| 2026-04-14 | 7.45x |
| 2026-04-13 | 7.32x |
| 2026-04-10 | 7.19x |
| 2026-04-09 | 7.23x |
| 2026-04-08 | 7.15x |
| 2026-04-07 | 6.93x |
| 2026-04-06 | 6.99x |
| 2026-04-02 | 7.02x |
| 2026-04-01 | 7.08x |
| 2026-03-31 | 7.15x |
| 2026-03-30 | 7.01x |
| 2026-03-27 | 6.95x |
| 2026-03-26 | 7.11x |
| 2026-03-25 | 7.10x |
| 2026-03-24 | 7.05x |
| 2026-03-23 | 7.19x |
| 2026-03-20 | 7.19x |
| 2026-03-19 | 7.30x |
| 2026-03-18 | 7.30x |
| 2026-03-17 | 7.43x |
| 2026-03-16 | 7.30x |
| 2026-03-13 | 7.27x |
| 2026-03-12 | 7.22x |
| 2026-03-11 | 7.34x |
| 2026-03-10 | 7.34x |
| 2026-03-09 | 7.42x |
| 2026-03-06 | 7.48x |
| 2026-03-05 | 7.60x |
| 2026-03-04 | 7.56x |
| 2026-03-03 | 7.60x |
| 2026-03-02 | 7.77x |
| 2026-02-27 | 7.87x |
| 2026-02-26 | 26.59x |
| 2026-02-25 | 26.08x |
| 2026-02-24 | 25.62x |
| 2026-02-23 | 25.41x |
| 2026-02-20 | 25.49x |
| 2026-02-19 | 25.67x |
| 2026-02-18 | 26.03x |
| 2026-02-17 | 25.71x |
| 2026-02-13 | 26.21x |
| 2026-02-12 | 26.32x |
| 2026-02-11 | 27.84x |
| 2026-02-10 | 27.56x |
| 2026-02-09 | 26.90x |
| 2026-02-06 | 26.91x |
| 2026-02-05 | 26.60x |
| 2026-02-04 | 26.47x |
| 2026-02-03 | 26.26x |
| 2026-02-02 | 26.58x |
| 2026-01-30 | 26.60x |
| 2026-01-29 | 26.47x |
| 2026-01-28 | 26.50x |
| 2026-01-27 | 26.77x |
| 2026-01-26 | 27.16x |
| 2026-01-23 | 27.13x |
| 2026-01-22 | 27.50x |
| 2026-01-21 | 27.53x |
| 2026-01-20 | 27.14x |
| 2026-01-16 | 27.29x |
| 2026-01-15 | 27.55x |
| 2026-01-14 | 27.44x |
| 2026-01-13 | 27.44x |
| 2026-01-12 | 28.99x |
| 2026-01-09 | 29.11x |
| 2026-01-08 | 29.01x |
| 2026-01-07 | 28.59x |
| 2026-01-06 | 28.30x |
| 2026-01-05 | 27.65x |
| 2026-01-02 | 27.16x |
| 2025-12-31 | 27.22x |
| 2025-12-30 | 27.47x |
| 2025-12-29 | 27.45x |
| 2025-12-26 | 27.56x |
| 2025-12-24 | 27.48x |
| 2025-12-23 | 27.58x |
| 2025-12-22 | 27.64x |
| 2025-12-19 | 27.87x |
| 2025-12-18 | 27.62x |
| 2025-12-17 | 27.42x |
| 2025-12-16 | 27.59x |
| 2025-12-15 | 27.95x |
| 2025-12-12 | 28.25x |
| 2025-12-11 | 28.19x |
| 2025-12-10 | 27.95x |
| 2025-12-09 | 27.46x |
| 2025-12-08 | 28.14x |
| 2025-12-05 | 28.92x |
| 2025-12-04 | 28.87x |
| 2025-12-03 | 28.87x |
| 2025-12-02 | 28.96x |
| 2025-12-01 | 28.95x |
| 2025-11-28 | 28.87x |
| 2025-11-26 | 28.88x |
| 2025-11-25 | 29.01x |
| 2025-11-24 | 28.36x |
| 2025-11-21 | 28.22x |
| 2025-11-20 | 27.29x |
| 2025-11-19 | 26.69x |
| 2025-11-18 | 26.58x |
| 2025-11-17 | 26.38x |
| 2025-11-14 | 26.24x |
| 2025-11-13 | 26.12x |
| 2025-11-12 | 25.74x |
| 2025-11-11 | 25.75x |
| 2025-11-10 | 25.18x |
| 2025-11-07 | 25.10x |
| 2025-11-06 | 23.66x |
| 2025-11-05 | 24.69x |
| 2025-11-04 | 24.89x |
| 2025-11-03 | 24.78x |
| 2025-10-31 | 24.99x |
| 2025-10-30 | 25.05x |
| 2025-10-29 | 25.16x |
| 2025-10-28 | 25.42x |
| 2025-10-27 | 25.65x |
| 2025-10-24 | 25.53x |
| 2025-10-23 | 25.72x |
| 2025-10-22 | 25.83x |
| 2025-10-21 | 25.86x |
| 2025-10-20 | 25.86x |
| 2025-10-17 | 25.70x |
| 2025-10-16 | 25.53x |
| 2025-10-15 | 25.56x |
| 2025-10-14 | 25.54x |
| 2025-10-13 | 25.41x |
| 2025-10-10 | 25.33x |
| 2025-10-09 | 25.61x |
| 2025-10-08 | 25.76x |
| 2025-10-07 | 25.70x |
| 2025-10-06 | 26.06x |
| 2025-10-03 | 26.11x |
| 2025-10-02 | 26.25x |
| 2025-10-01 | 25.89x |
| 2025-09-30 | 25.88x |
| 2025-09-29 | 25.71x |
| 2025-09-26 | 25.52x |
| 2025-09-25 | 25.31x |
| 2025-09-24 | 25.62x |
| 2025-09-23 | 25.97x |
| 2025-09-22 | 26.06x |
| 2025-09-19 | 26.05x |
| 2025-09-18 | 26.19x |
| 2025-09-17 | 26.13x |
| 2025-09-16 | 26.14x |
| 2025-09-15 | 25.93x |
| 2025-09-12 | 25.97x |
| 2025-09-11 | 26.06x |
| 2025-09-10 | 25.48x |
| 2025-09-09 | 25.86x |
| 2025-09-08 | 26.25x |
| 2025-09-05 | 25.82x |
| 2025-09-04 | 25.75x |
| 2025-09-03 | 25.52x |
| 2025-09-02 | 25.62x |
| 2025-08-29 | 25.91x |
| 2025-08-28 | 25.81x |
| 2025-08-27 | 25.86x |
| 2025-08-26 | 25.87x |
| 2025-08-25 | 25.83x |
| 2025-08-22 | 26.01x |
| 2025-08-21 | 25.66x |
| 2025-08-20 | 25.85x |
| 2025-08-19 | 25.72x |
| 2025-08-18 | 25.38x |
| 2025-08-15 | 25.53x |
| 2025-08-14 | 25.93x |
| 2025-08-13 | 26.20x |
| 2025-08-12 | 25.68x |
| 2025-08-11 | 25.63x |
| 2025-08-08 | 25.97x |
| 2025-08-07 | 25.65x |
| 2025-08-06 | 24.86x |
| 2025-08-05 | 24.83x |
| 2025-08-04 | 25.00x |
| 2025-08-01 | 24.68x |
| 2025-07-31 | 24.60x |
| 2025-07-30 | 24.95x |
| 2025-07-29 | 25.08x |
| 2025-07-28 | 25.12x |
| 2025-07-25 | 25.33x |
| 2025-07-24 | 25.16x |
| 2025-07-23 | 25.26x |
| 2025-07-22 | 24.94x |
| 2025-07-21 | 24.81x |
| 2025-07-18 | 25.02x |
| 2025-07-17 | 25.14x |
| 2025-07-16 | 24.96x |
| 2025-07-15 | 25.10x |
| 2025-07-14 | 25.19x |
| 2025-07-11 | 25.13x |
| 2025-07-10 | 25.58x |
| 2025-07-09 | 25.21x |
| 2025-07-08 | 25.41x |
| 2025-07-07 | 25.66x |
| 2025-07-03 | 26.15x |
| 2025-07-02 | 26.09x |
| 2025-07-01 | 26.02x |
| 2025-06-30 | 25.57x |
| 2025-06-27 | 25.49x |
| 2025-06-26 | 25.31x |
| 2025-06-25 | 25.38x |
| 2025-06-24 | 25.38x |
| 2025-06-23 | 25.01x |
| 2025-06-20 | 25.08x |
| 2025-06-18 | 24.88x |
| 2025-06-17 | 24.90x |
| 2025-06-16 | 25.27x |
| 2025-06-13 | 25.13x |
| 2025-06-12 | 25.24x |
| 2025-06-11 | 25.26x |
| 2025-06-10 | 25.51x |
| 2025-06-09 | 25.37x |
| 2025-06-06 | 25.35x |
| 2025-06-05 | 25.47x |
| 2025-06-04 | 25.42x |
| 2025-06-03 | 25.23x |
| 2025-06-02 | 24.98x |
| 2025-05-30 | 24.98x |
Showing the most recent 260 of 555 data points. The chart above shows the full history.
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson